Search research articles
Contact Us
Filters
Showing results (291-300 of 502) with videos related to
Page
of 51
Sort By:
British Journal of Pharmacology
|
December 1, 1990
Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function
W R Galpern, L G Miller, D J Greenblatt, et al.
Journal of Clinical Pharmacology
|
August 1, 1979
Single-dose kinetics of prazepam, a precursor of desmethyldiazepam
M D Allen, D J Greenblatt, J S Harmatz, et al.
British Journal of Pharmacology
|
July 1, 1990
Caffeine-induced behavioural stimulation is dose- and concentration-dependent
G B Kaplan, N T Tai, D J Greenblatt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 21, 2000
Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4
E Störmer, L L von Moltke, R I Shader, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1988
Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function
L G Miller, D J Greenblatt, J G Barnhill, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1980
Diazepam disposition determinants
D J Greenblatt, M D Allen, J S Harmatz, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1977
Acute overdosage with benzodiazepine derivatives
D J Greenblatt, M D Allen, B J Noel, et al.
The American Journal of Drug and Alcohol Abuse
|
January 1, 1990
The diagnosis and treatment of panic disorder in alcoholics: three cases
D H Baron, B F Sands, D A Ciraulo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 22, 2000
In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions
J S Warrington, R I Shader, L L von Moltke, et al.
Journal of Clinical Psychopharmacology
|
October 3, 1999
Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions
D J Greenblatt, L L von Moltke, J S Harmatz, et al.
Page
of 51
Search research articles
Search
Showing results (291-300 of 502) with videos related to
Sort By:
Page
of 51
British Journal of Pharmacology
|
December 1, 1990
Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function
W R Galpern, L G Miller, D J Greenblatt, et al.
Journal of Clinical Pharmacology
|
August 1, 1979
Single-dose kinetics of prazepam, a precursor of desmethyldiazepam
M D Allen, D J Greenblatt, J S Harmatz, et al.
British Journal of Pharmacology
|
July 1, 1990
Caffeine-induced behavioural stimulation is dose- and concentration-dependent
G B Kaplan, N T Tai, D J Greenblatt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 21, 2000
Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4
E Störmer, L L von Moltke, R I Shader, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1988
Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function
L G Miller, D J Greenblatt, J G Barnhill, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1980
Diazepam disposition determinants
D J Greenblatt, M D Allen, J S Harmatz, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1977
Acute overdosage with benzodiazepine derivatives
D J Greenblatt, M D Allen, B J Noel, et al.
The American Journal of Drug and Alcohol Abuse
|
January 1, 1990
The diagnosis and treatment of panic disorder in alcoholics: three cases
D H Baron, B F Sands, D A Ciraulo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 22, 2000
In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions
J S Warrington, R I Shader, L L von Moltke, et al.
Journal of Clinical Psychopharmacology
|
October 3, 1999
Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions
D J Greenblatt, L L von Moltke, J S Harmatz, et al.
Page
of 51